Patients struggle to afford glucagon-like peptide-1 (GLP-1) medications for diabetes; doctors see potential and pitfalls in new ChatGPT model’s humanlike conversations; Medicare payment reform efforts focus on inflation adjustments and payment model overhauls.
Patients Face Medication Shortages, High Costs Amid Growing Demand for GLP-1 Drugs
Patients with diabetes are experiencing supply shortages and insurance hurdles for glucagon-like peptide-1 (GLP-1) agonists, leaving many without access to the medications they need to stay healthy, according to Kaiser Health News. These drugs, essential for managing their blood sugar levels, have become increasingly difficult to obtain, especially for lower-income individuals with high-deductible health plans, Medicaid, Medicare, or marketplace plans. The rising demand for these medications, fueled by their effectiveness and new FDA indications, has contributed to these access hurdles, experts say.
Next-Gen ChatGPT’s Real-Time Voice Interactions Could Revolutionize Health Care via Chatbots
OpenAI's latest ChatGPT update, GPT-4o, introduced advanced real-time voice interactions, with potential implications for patient engagement in health care, according to Axios. While this technology could make health advice more accessible, doctors have expressed concerns about the chatbot's tendency to confidently provide misinformation and the possibility of patients overrelying on it. Experts envision a future where artificial intelligence complements medical advice, assisting with tasks like lifestyle changes and emergency responses, but caution remains about the limitations and potential risks of this technology.
Senate Finance Committee Takes Aim at Medicare Physician Pay Reform
The Senate Finance Committee has launched a bipartisan initiative to address declining Medicare physician reimbursements, marking the most significant review in nearly a decade, according to Modern Healthcare. The proposed reforms aim to link physician pay to inflation, encourage cost-effective alternative payment models, and simplify the burdensome Merit-based Incentive Payment System. This effort seeks to ensure fair compensation for physicians, which is crucial for maintaining access to quality care for Medicare beneficiaries.
National Data Show Rising Risk, Cost of CKD in Patients With Acute Myocardial Infarction
April 10th 2025A series of new studies from the National Kidney Foundation Spring Clinical Meeting exhibit the association between impaired kidney function and prolonged hospital stays, higher charges, and greater resource utilization.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More